Randomized study to evaluate the use of high-dose therapy as part of primary treatment for "aggressive" lymphoma.

Ulrich Kaiser, Irmgard Uebelacker, Ulrich Abel, Josef Birkmann (Co-author), Lorenz Trümper, Harald Schmalenberg, Tunca Karakas, Bernd Metzner, Dieter K Hossfeld, Helge G Bischoff, Astrid Franke, Marcel Reiser, Peter Müller, Luisa Mantovani, Marc Grundeis, Frank Rothmann, Cay-Uwe von Seydewitz, Rolf M Mesters, Ernst U Steinhauer, Dorothea KrahlKurt Schumacher, Michael Kneba, Michael Baudis, Norbert Schmitz, Rüdiger Pfab, Hubert Köppler, Reza Parwaresch, Michael Pfreundschuh, Klaus Havemann

    Research output: Contribution to journalOriginal Article (Journal)peer-review

    104 Citations (Web of Science)
    Original languageEnglish
    Pages (from-to)4413-4419
    JournalJOURNAL OF CLINICAL ONCOLOGY
    Volume20
    Issue number22
    DOIs
    Publication statusPublished - 2002

    Keywords

    • NON-HODGKINS-LYMPHOMA
    • BONE-MARROW TRANSPLANTATION
    • COMPLETE REMISSION
    • CHEMOTHERAPY
    • MULTICENTER
    • GRADE
    • CLASSIFICATION
    • TRIAL
    • CHOP

    Cite this